Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Operating Income: 2019-2024

Historic Operating Income for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to -$166.6 million.

  • Caribou Biosciences' Operating Income rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$166.6 million for FY2024, which is 43.56% down from last year.
  • As of FY2024, Caribou Biosciences' Operating Income stood at -$166.6 million, which was down 43.56% from -$116.1 million recorded in FY2023.
  • Caribou Biosciences' Operating Income's 5-year high stood at -$36.1 million during FY2020, with a 5-year trough of -$166.6 million in FY2024.
  • Moreover, its 3-year median value for Operating Income was -$116.1 million (2023), whereas its average is -$129.7 million.
  • Data for Caribou Biosciences' Operating Income shows a maximum YoY plummeted of 85.41% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Caribou Biosciences' Operating Income stood at -$36.1 million in 2020, then crashed by 85.41% to -$67.0 million in 2021, then plummeted by 58.85% to -$106.4 million in 2022, then fell by 9.08% to -$116.1 million in 2023, then tumbled by 43.56% to -$166.6 million in 2024.